Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
General Pulmonary
Does rituximab have a potential role in the management of immune checkpoint inhibitor induced pneumonitis?
Related Questions
Does the presence of a bloody aspirate reduce the diagnostic yield of EBUS bronchoscopy, and if so, what strategies can be employed to minimize its occurrence?
What are your vaccine recommendations while patients are on biologics?
How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?
What criteria do you use to determine if a change is clinically significant while evaluating PFTs?
When you interpret a PFT officially, do you include a comparison to an older PFT on your report?
Is it clinically necessary to provide supplemental oxygen to patients with mild, asymptomatic hypoxemia only during activity while they are recovering from an acute respiratory illness?
How do you manage PEEP in a morbidly patient with severe hypoxia who is already proned with no access to esophageal ballon?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
What is the duration of steroids that you prescribe for organizing pneumonia?
How would you manage an intermediate-risk segmental PE that is transiently provoked after a knee surgery?
